Sunvozertinib: First Approval
This article summarizes the milestones in the development of sunvozertinib leading to this first approval for metastatic NSCLC withEGFR exon20ins.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research
More News: AstraZeneca | Cancer | Cancer & Oncology | Chemotherapy | China Health | Drugs & Pharmacology | Lung Cancer | Non-Small Cell Lung Cancer | Oral Cancer | Study